World-first: Scientists just treated the first human with a therapy designed to make old cells young again
For the first time, a person has received a gene therapy aimed at “partially reprogramming” aging cells, essentially nudging them back toward a younger state without turning them into stem cells.
The trial, run by Life Biosciences, targets glaucoma by trying to regenerate damaged optic nerve cells in the eye. The huge question now: can cellular rejuvenation work safely in humans?
It may be one of the most important first tests of whether the biology of aging can be therapeutically reversed.













